Compounds > fludarabine

fludarabine and Lung Diseases

fludarabine has been researched along with Lung Diseases in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's5 (41.67)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BA; Ding, BH; Ding, JH; Li, YF; Qian, J; Yu, ZP1
Chambellan, A; Chevallier, P; Delasalle, B; Delaunay, J; Dirou, S; Germaud, P; Guillaume, T; Lemarchand, P; Malard, F; Mohty, M; Moreau, P1
Alousi, AM; Anderlini, P; Champlin, RE; Fanale, MA; Hagemeister, FB; Hosing, CM; Khouri, IF; Ledesma, C; Neelapu, S; Nieto, Y; Oki, Y; Plair, T; Popat, UR; Romaguera, JE; Saliba, RM; Shpall, EJ; Younes, A1
Baxter-Lowe, LA; Cairo, MS; Dalal, R; Dozor, AJ; Fabricatore, S; Harrison, L; Jin, Z; Majzner, R; Morris, E; Sandoval, C; van de Ven, C; Wolownik, K1
Disel, U; Karakoc, E; Paydas, S; Yavuz, S1
Basmaji, N; Garg, MS; Garg, S1
Gajewski, JL; Hicks, K; Peng, D1
Aguado, JM; Díaz-Pedroche, C; Folgueira, D; Giménez-Mesa, E; Lizasoain, M1
Byrd, JC; Diehl, LF; Hargis, JB; Hospenthal, DR; Kester, KE; Knutson, SW1
Blanche, P; Colbert, N; Galezowski, N; Golstein, FW; Lasoudris, J; Mainardi, JL; Maulin, L; Nguyen, TB1
Molinari, A; Poletti, G; Poletti, V; Salvucci, M; Zaccaria, A; Zanchini, R; Zuffa, E1
Abonour, R; Kim, K; Longo, WL; Mosher, DF; Turman, NJ; Vidarsson, B; Wiersma, SR; Williams, EC; Woodson, RD1

Reviews

1 review(s) available for fludarabine and Lung Diseases

ArticleYear
Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature.
    American journal of hematology, 2002, Volume: 70, Issue:3

    Topics: Aged; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases; Prednisone; Tomography, X-Ray Computed; Vidarabine

2002

Other Studies

11 other study(ies) available for fludarabine and Lung Diseases

ArticleYear
An anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitution.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lung Diseases; Lymphocytes; Male; Middle Aged; Mucositis; Outcome Assessment, Health Care; Proportional Hazards Models; Quality of Life; Recovery of Function; Retrospective Studies; Surveys and Questionnaires; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult

2013
Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT.
    Bone marrow transplantation, 2014, Volume: 49, Issue:5

    Topics: Administration, Intravenous; Adult; Aged; Antilymphocyte Serum; Busulfan; Female; Follow-Up Studies; Hematologic Diseases; Humans; Immunosuppressive Agents; Lung Diseases; Lymphocyte Depletion; Male; Middle Aged; Myeloablative Agonists; Respiratory Function Tests; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult

2014
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:7

    Topics: Adult; Brentuximab Vedotin; Deoxycytidine; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Lung Diseases; Male; Melphalan; Middle Aged; Nausea; Remission Induction; Salvage Therapy; Skin Diseases; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult

2016
Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.
    Bone marrow transplantation, 2016, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Busulfan; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases; Male; Myeloablative Agonists; Respiratory Function Tests; Transplantation Conditioning; Vidarabine; Young Adult

2016
Severe pulmonary toxicity associated with fludarabine and possible contribution of rituximab.
    Chemotherapy, 2010, Volume: 56, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Humans; Lung Diseases; Lymphoma, Follicular; Male; Middle Aged; Rituximab; Severity of Illness Index; Vidarabine

2010
Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Factor VIIa; Fatal Outcome; Female; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Myelomonocytic, Acute; Lung Diseases; Pneumothorax; Pulmonary Alveoli; Recombinant Proteins; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2002
[Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine].
    Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:1

    Topics: Aged; Antineoplastic Agents; Dyspnea; Female; Fever; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vidarabine

2006
Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis.
    American journal of hematology, 1995, Volume: 49, Issue:2

    Topics: Antineoplastic Agents; Biopsy; Bronchoscopy; Humans; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Opportunistic Infections; Pneumonia, Pneumocystis; Vidarabine

1995
[Nocardia nova pulmonary infection under treatment with fludarabine].
    Presse medicale (Paris, France : 1983), 1997, Jul-05, Volume: 26, Issue:23

    Topics: Aged; Antineoplastic Agents; Humans; Lung Diseases; Male; Nocardia Infections; Vidarabine

1997
Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
    Haematologica, 2000, Volume: 85, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hemorrhage; Humans; Infant, Newborn; Leukemia; Leukemia, Myeloid, Acute; Lung Diseases; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Distress Syndrome, Newborn; Staphylococcal Infections; Vidarabine

2000
Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
    Leukemia & lymphoma, 2001, Volume: 41, Issue:3-4

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Infections; Infusion Pumps; Leukemia; Lung Diseases; Male; Middle Aged; Nervous System Diseases; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; Vidarabine

2001